However, in another study including patients with dyslipidemia, the higher DNA methylation level of four CpG dinucleotides in the PON1 promoter region was associated with poorer clopidogrel response, which according to authors resulted from the lower expression of PON1 mRNA [68]. Here, PON1 is linked to metabolic syndrome.